Bio Reference Laboratories Inc (BRLI) financial statements (2020 and earlier)

Company profile

Business Address 481 EDWARD H ROSS DR
ELMWOOD PARK, NJ 07407-3118
State of Incorp. NJ
Fiscal Year End October 31
SIC 8071 - Medical Laboratories (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

4/30/2015
TTM
10/31/2014
10/31/2013
10/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 181825
Cash and cash equivalents 181825
Receivables 263206153
Inventory, net of allowances, customer advances and progress billings 211915
Inventory 211915
Prepaid expense and other current assets95
Other current assets 10 
Other undisclosed current assets 404225
Total current assets: 352295224
Noncurrent Assets
Property, plant and equipment 666650
Long-term investments and receivables 555
Long-term investments 555
Intangible assets, net (including goodwill) 505230
Goodwill 353523
Intangible assets, net (excluding goodwill) 14166
Deposits noncurrent assets 111
Other noncurrent assets 1 
Prepaid expense and other noncurrent assets11
Other undisclosed noncurrent assets (63)(64)(48)
Total noncurrent assets: 616139
Other undisclosed assets 666650
TOTAL ASSETS: 479422313
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 10310068
Accounts payable 716241
Employee-related liabilities 162016
Taxes payable 161810
Debt 764
Other undisclosed current liabilities 3529 
Total current liabilities: 14513472
Noncurrent Liabilities
Long-term debt and lease obligation 151414
Long-term debt, excluding current maturities 344
Capital lease obligations 12119
Other undisclosed noncurrent liabilities  2 
Total noncurrent liabilities: 151614
Total liabilities: 16015086
Stockholders' equity
Stockholders' equity attributable to parent 319272227
Common stock 000
Additional paid in capital 403941
Retained earnings 279232186
Total stockholders' equity: 319272227
TOTAL LIABILITIES AND EQUITY: 479422313

Income statement (P&L) ($ in millions)

4/30/2015
TTM
10/31/2014
10/31/2013
10/31/2012
Revenues
(Revenue, Net)
 832715662
Cost of revenue
(Cost of Goods and Services Sold)
 (462)(393)(338)
Gross profit: 370323324
Operating expenses (212)(224)(167)
Other undisclosed operating loss (75)(16)(80)
Operating income: 838276
Nonoperating expense (3)(0)(2)
Investment income, nonoperating (0)1(0)
Other nonoperating expense (2)(1)(2)
Interest and debt expense (2)(2)(1)
Other undisclosed income from continuing operations before equity method investments, income taxes 312
Income from continuing operations before equity method investments, income taxes: 818175
Loss from equity method investments (0)(0)(0)
Income from continuing operations before income taxes: 818174
Income tax expense (34)(35)(32)
Net income attributable to parent: 474542
Other undisclosed net income available to common stockholders, basic 000
Net income available to common stockholders, diluted: 474642

Comprehensive Income ($ in millions)

4/30/2015
TTM
10/31/2014
10/31/2013
10/31/2012
Net income: 474542
Comprehensive income, net of tax, attributable to parent: 474542

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: